126 related articles for article (PubMed ID: 31432503)
21. Lead induces the up-regulation of the protein arginine methyltransferase 5 possibly by its promoter demethylation.
Ghosh K; Chatterjee B; Kanade SR
Biochem J; 2018 Aug; 475(16):2653-2666. PubMed ID: 30054435
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of the human PRMT5:MEP50 complex.
Antonysamy S; Bonday Z; Campbell RM; Doyle B; Druzina Z; Gheyi T; Han B; Jungheim LN; Qian Y; Rauch C; Russell M; Sauder JM; Wasserman SR; Weichert K; Willard FS; Zhang A; Emtage S
Proc Natl Acad Sci U S A; 2012 Oct; 109(44):17960-5. PubMed ID: 23071334
[TBL] [Abstract][Full Text] [Related]
23. Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.
Ho MC; Wilczek C; Bonanno JB; Xing L; Seznec J; Matsui T; Carter LG; Onikubo T; Kumar PR; Chan MK; Brenowitz M; Cheng RH; Reimer U; Almo SC; Shechter D
PLoS One; 2013; 8(2):e57008. PubMed ID: 23451136
[TBL] [Abstract][Full Text] [Related]
24. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
[TBL] [Abstract][Full Text] [Related]
25. Cryo-electron microscopy structure of a human PRMT5:MEP50 complex.
Timm DE; Bowman V; Madsen R; Rauch C
PLoS One; 2018; 13(3):e0193205. PubMed ID: 29518110
[TBL] [Abstract][Full Text] [Related]
26. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
Bai S; Kitaura H; Zhao H; Chen J; Müller JM; Schüle R; Darnay B; Novack DV; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Oct; 115(10):2742-51. PubMed ID: 16184196
[TBL] [Abstract][Full Text] [Related]
27. A novel WD repeat protein component of the methylosome binds Sm proteins.
Friesen WJ; Wyce A; Paushkin S; Abel L; Rappsilber J; Mann M; Dreyfuss G
J Biol Chem; 2002 Mar; 277(10):8243-7. PubMed ID: 11756452
[TBL] [Abstract][Full Text] [Related]
28. ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.
Jeong BC; Kim JH; Kim K; Kim I; Seong S; Kim N
Bone; 2017 Feb; 95():33-40. PubMed ID: 27829167
[TBL] [Abstract][Full Text] [Related]
29. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
30. Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex.
Krzyzanowski A; Gasper R; Adihou H; Hart P'; Waldmann H
Chembiochem; 2021 Jun; 22(11):1908-1914. PubMed ID: 33624332
[TBL] [Abstract][Full Text] [Related]
31. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
[TBL] [Abstract][Full Text] [Related]
32. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic insight into osteoclast differentiation in osteoimmunology.
Takayanagi H
J Mol Med (Berl); 2005 Mar; 83(3):170-9. PubMed ID: 15776286
[TBL] [Abstract][Full Text] [Related]
34. [The Relationship Study between Expressions of P2X5 Receptor and Deficiency-cold Syndrome/Deficiency-heat Syndrome at Various Ambient Temperatures].
Yang LP; Yu HJ; Huang R; Li XM; Zhan XH; Hou JL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 May; 35(5):559-62. PubMed ID: 26159019
[TBL] [Abstract][Full Text] [Related]
35. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T
J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684
[TBL] [Abstract][Full Text] [Related]
36. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
37. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
38. Notch signaling promotes osteoclast maturation and resorptive activity.
Ashley JW; Ahn J; Hankenson KD
J Cell Biochem; 2015 Nov; 116(11):2598-609. PubMed ID: 25914241
[TBL] [Abstract][Full Text] [Related]
39. Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel.
Torres GE; Haines WR; Egan TM; Voigt MM
Mol Pharmacol; 1998 Dec; 54(6):989-93. PubMed ID: 9855626
[TBL] [Abstract][Full Text] [Related]
40. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]